Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

RETNLB antibody

RETNLB Reactivity: Human ELISA, IHC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN2422115
  • Target See all RETNLB Antibodies
    RETNLB (Resistin Like beta (RETNLB))
    Reactivity
    • 45
    • 13
    Human
    Host
    • 54
    • 2
    • 1
    • 1
    Rabbit
    Clonality
    • 55
    • 3
    Polyclonal
    Conjugate
    • 26
    • 9
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This RETNLB antibody is un-conjugated
    Application
    • 49
    • 33
    • 13
    • 13
    • 6
    • 4
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
    Purification
    Affinity purification
    Immunogen
    Recombinant protein of human RETNLB
    Isotype
    IgG
    Top Product
    Discover our top product RETNLB Primary Antibody
  • Application Notes
    IHC 1:50-1:200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.3 mg/mL
    Buffer
    PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
    Preservative
    Sodium azide
    Handling Advice
    Avoid freeze / thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    RETNLB (Resistin Like beta (RETNLB))
    Alternative Name
    RETNLB (RETNLB Products)
    Synonyms
    FIZZ1 antibody, FIZZ2 antibody, HXCP2 antibody, RELM-beta antibody, RELMb antibody, RELMbeta antibody, XCP2 antibody, RETNLB antibody, 9030012B21Rik antibody, Fizz2 antibody, Relmb antibody, Xcp3 antibody, resistin like beta antibody, RETNLB antibody, Retnlb antibody
    Background
    Resistin-like betais aproteinthat in humans is encoded by theRETNLBgene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.
    Pathways
    Hormone Activity
You are here:
Support